<i>UGT2B7</i>Genetic Polymorphisms are Associated with the Withdrawal Symptoms in Methadone Maintenance Patients

Jia-Ni Tian, Ing-Kang Ho, Hsiao‐Hui Tsou, Chiu‐Ping Fang, Chin‐Fu Hsiao, Chia‐Hui Chen, Happy Kuy‐Lok Tan, Linen Nymphas Lin, Chi‐Shin Wu, Lien‐Wen Su,

Pharmacogenomics · 2012 · 33 citations · 29 references

Concepts

Abstract

AIM: To test whether the genetic polymorphisms within the gene encoding the UGT2B7 gene may have an impact on methadone treatment. MATERIALS & METHODS: Twelve SNPs in UGT2B7 were selected. 366 methadone maintenance treatment patients in Taiwan were recruited and genotyped. RESULTS: In a genotype recessive model, rs6600879, rs6600880, rs4554144, rs11940316, rs7438135, rs7662029, rs7668258, rs7439366, rs4292394 and rs6600893 showed significant associations with severity of withdrawal symptoms (permutation p < 0.002), pupil size (permutation p < 0.048) and tremor (permutation p < 0.008). Haplotypes of GATCAGCCGC and CTCTGATTCT were significantly associated with pupil size score and tremor score (p < 0.034). CONCLUSION: These results suggest that SNPs of the UGT2B7 gene may play important roles in opiate withdrawal symptoms.

References

29